GSA CAPITAL PARTNERS LLP - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,091
+140.9%
540,250
+103.6%
0.18%
+108.1%
Q1 2023$868
-33.0%
265,372
-19.0%
0.09%
-46.6%
Q4 2022$1,295
-99.9%
327,793
+66.4%
0.16%
+2.5%
Q3 2022$1,182,000
+92.8%
196,977
+106.7%
0.16%
+70.7%
Q2 2022$613,000
-45.5%
95,310
-30.0%
0.09%
-39.1%
Q1 2022$1,124,000136,1050.15%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$673,139,0008.60%
Trustees of Columbia University in the City of New York 281,250$5,530,0008.17%
Crestline Management, LP 3,210,937$63,127,0005.44%
Omega Fund Management, LLC 843,750$16,588,0001.88%
Alphabet Inc. 2,812,500$55,294,0001.13%
SB Management Ltd 2,625,153$51,611,0000.61%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,508,111$88,629,0000.53%
HARVARD MANAGEMENT CO INC 468,749$9,216,0000.53%
Avidity Partners Management LP 778,597$15,307,0000.41%
Dragoneer Investment Group 1,500,000$29,490,0000.38%
View complete list of SANA BIOTECHNOLOGY INC shareholders